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ABSTRACT 
The Effects of 8 Weeks of Low Dose Supplementation of Creatine and Sodium 
Bicarbonate on Exercise Performance 
Amanda Jessica Morris 
Short-term (3-7 days), high doses of creatine (20g/d) and/or sodium bicarbonate (0.5g/kg 
body weight) supplementation increase exercise performance during short term high 
intensity activities; however, it remains unclear whether long-term, low doses of these 
supplements have a positive impact on exercise performance. The purpose of this study 
was to determine the effects of long-term (8 weeks), low dose creatine supplementation 
on exercise performance, and whether combining creatine and sodium bicarbonate 
supplementation has an additive effect.  Sixty-three healthy, habitually active, adults (28 
M, 35 W; 22+2 years; 23+ 3 BMI) were randomly assigned by sex to one of three 
supplement groups: placebo (PL), creatine only (3g/day; Cr), or creatine plus sodium 
bicarbonate (3g creatine plus 1g sodium bicarbonate; Cr+Sb) for 8 weeks.  Before and 
after supplementation subjects completed two exercise performance tests on separate 
days. Subjects completed repeated Wingate sprint tests (6 x 10 second sprints) and 
changes in the slope across the 6 sprints (rate of decline) was analyzed between groups. 
We also collected 5 km time-trial and the data were analyzed using repeated measures 
ANOVA.  In the repeated sprint test, peak power output slope was significantly 
decreased (P=0.04) in PL (-83%) and Cr+Sb (-82%) but did not change in Cr alone and 
was significantly better (P=0.03) than Pl and Cr+Sb.  Similarly, mean power output slope 
significantly decreased (P<0.001) in PL (-73%) and Cr+Sb (-150%), but not in Cr alone.  
In the 5 k time-trial, PL (-0.4%) and Cr+Sb (+0.5%) had no significant change (P>0.05) 
	  v 
in time to completion.  However, Cr alone significantly improved time to completion (-
3%; P=0.01).  Taken together, these data suggest that long-term, low dose creatine 
supplementation increases exercise performance but adding sodium bicarbonate 
supplementation has no beneficial impact on exercise performance.  
 
Keywords: creatine, sodium bicarbonate, low dose, cycling, exercise performance 
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Chapter 1 
Introduction 
Statement of the Problem 
Endurance athletes are constantly seeking ways to increase exercise performance. 
This includes, but is not limited to altering carbohydrate intake, environmental training 
(e.g. live high, train low) and nutritional ergogenic aids. Dietary supplements have a 
potential ergogenic effect, and are the most common method used by athletes to increase 
exercise performance as up to 76% of athletes use some dietary supplement (3). These 
dietary supplements include antioxidants, herbal supplements, aspartates, caffeine, amino 
acids, and many others but empirical data is limited. However, two of the most 
investigated dietary supplements are creatine and sodium bicarbonate supplements. 
Creatine supplementation is widely regarded as having a major impact on high 
intensity exercise performance. Many studies have shown the positive effects of creatine 
on high intensity, short duration activities (22, 24, 25, 28, 35). For example, Ziegenfuss et 
al (62) found that 3 days of creatine supplementation (0.35g/kg fat free mass), relative to 
placebo, improved total work in repeated cycle sprint performance. Total work in the first 
sprint was significantly (P<0.04) higher in the creatine group than in placebo, and peak 
power in sprints 2 through 6 was significantly (p<0.01) higher in the creatine group than 
in placebo. Balsom et al (4) found that 6 days of creatine supplementation (20g/day), 
compared to placebo significantly (2.3% vs. 3.2%, p<0.05) attenuated the decline in 
repeated cycling sprints. Similarly, others found (2, 58) that short-term creatine 
supplementation compared to placebo significantly increased running and weight lifting 
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performance. Taken together, these data indicate that short-term creatine supplementation 
can markedly increase exercise performance.  
 Despite the well-documented efforts of creatine supplementation, most studies 
have examined the short-term effects of creatine (<7days), with a dosage of 15-20g/day 
(16, 17, 22, 24, 25). However, these higher doses of creatine may cause gastrointestinal 
distress such as nausea, vomiting, and diarrhea, which may impair or hinder exercise 
performance (55). Thus athletes need an optimal way to ingest creatine supplementation 
to increase exercise performance and minimize side effects.  
 Surprisingly, few studies have examined the benefits of long term (>3 weeks), 
low dose creatine supplementation, which may minimize unwanted side effects (11, 25, 
26, 28). For example, Rawson et al (49) found that 6 weeks of low-dose creatine 
supplementation (1.7-2.9 g/day) significantly (p<0.05) increased resistance to fatigue 
during resistance exercise in men and women compared to placebo.  Similarly, Burke et 
al (11) found that 21 days of creatine supplementation (~7.7g/day), compared to placebo, 
significantly increased peak force (23% vs. 13%, p<0.05), power output (21% vs. 12%, 
p<0.05), total work (68% vs. 16%, p<0.05) and time to fatigue during resistance exercise 
(p=0.05). These studies provide initial evidence that creatine supplementation lasting >3 
weeks increased resistance exercise performance. However, it remains unclear whether 
cycling exercise, which is more common for endurance athletes, is effected by long-term 
(>3 weeks) creatine supplementation.  
In addition to the well-documented effects of creatine supplementation, sodium 
bicarbonate has gained considerable attention on increasing exercise performance 
through its buffering capacity (35). Several studies have shown positive effects of short-
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term and long-term supplementation of sodium bicarbonate on exercise performance (18, 
27, 3316, 23, 28). Lavender and Bird (33) found that short-term sodium bicarbonate 
supplementation, compared to placebo, significantly improved performance of cycling 
sprints. Average power output was significantly higher (p<0.05) in 8 out of 10 sprints and 
peak power output was significantly higher (p<0.02) in 2 out of 10 sprints. Similarly, 
other studies found that sodium bicarbonate supplementation, versus placebo, 
significantly increased exercise performance (27). Only one previous study examined the 
long-term effect of sodium bicarbonate supplementation. Edge et al (18) studied the 
effect of 8 weeks of sodium bicarbonate ingestion during interval training on muscle 
buffer capacity and short-term endurance capacity. Supplementation with sodium 
bicarbonate, compared to placebo, resulted in a significantly greater improvement in 
lactate threshold (26% vs. 15%, p=0.05) and a greater improvement in time to fatigue 
(164% vs. 123%, p=0.05). These data suggest that both short-term and long-term (8 
weeks) sodium bicarbonate supplementation may be beneficial in increasing exercise 
performance. 
Interestingly, only two published studies have examined the effects of combined 
creatine and sodium bicarbonate supplementation. Mero et al (39) found that a short-term 
creatine and sodium bicarbonate supplement significantly decreased swim time (p<0.05) 
compared to placebo. Recently, Barber et al (6) found that combined short-term creatine 
and sodium bicarbonate supplementation, compared to placebo and creatine alone, 
significantly increased relative peak power (p=0.002) and mean power in repeated 
cycling sprints. Also, combined creatine and sodium bicarbonate supplementation, 
compared to placebo and creatine alone, had the slowest rate of decline in relative peak 
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power during the six sprints. These data suggest that combined creatine and sodium 
bicarbonate supplementation may have a potential additive effect on performance. 
However, no published study has examined the long-term effects of combining these two 
supplements on exercise performance. Thus, there is a need to examine the effects of a 
low dose, long-term (>3 weeks) supplementation of creatine and sodium bicarbonate. 
 
Statement of Purpose 
The primary purpose of this study is to determine whether 8 weeks of creatine 
supplementation increases exercise performance. The secondary purpose is to determine 
if a combined supplementation of creatine and sodium bicarbonate has an additive effect 
on exercise performance.  
Research Hypotheses 
Primary Hypotheses: 
A low-dose, 8 week supplementation of creatine, compared to placebo:  
1. Will significantly improve performance in repeated sprints (increase: peak power, 
relative peak power, mean power, and relative peak power; decrease fatigue 
index). 
2. Will significantly increase performance in a 5-kilometer time trial (reduce time to 
completion). 
Secondary Hypotheses: 
A low-dose, 8 week combined supplementation of creatine and sodium bicarbonate, 
compared to placebo and creatine alone: 
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3. Will significantly increase performance in repeated sprints (increase: peak power, 
relative peak power, mean power, and relative peak power; decrease fatigue 
index). 
4. Will significantly increase performance in a 5-kilometer time trial (reduce time to 
completion). 
Significance 
This study is in response to the American College of Sports Medicine 
recommendation for more long-term (> 3 weeks) creatine supplementation studies on 
exercise performance and alleviating side effects (55). This study will be the first to 
determine the effects of 8 weeks of creatine supplementation on two different types of 
cycling exercise. To our knowledge, this is the first study to investigate the effects of a 
low dose, 8 week creatine and creatine plus sodium bicarbonate supplementation on 
exercise performance, both of which might minimize gastrointestinal distress and other 
potential side effects. Moreover, we will show evidence to help determine whether 
creatine plus sodium bicarbonate is more beneficial than creatine alone. The results of 
this study will benefit endurance athletes and coaches by providing a convenient, low-
dose, supplement to increase exercise performance. 
Definition of Terms 
ATP (adenosine triphosphate): ATP is a high-energy phosphate compound from which 
energy is derived (46).  
Creatine: Creatine is stored in the muscles as phosphocreatine, which serves as a readily 
available source of ATP (46). Supplementation with creatine is theorized to increase 
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stores of PCr in the muscle allowing for greater exercise performance through better 
maintenance of ATP levels. (46)  
Sodium Bicarbonate (NAHCO3): Supplementation with sodium bicarbonate is theorized 
to improve performance by increasing buffering capacity, reducing the interference of 
hydrogen ions on ATP production and the contractile process (35).  
Peak Power: Highest mechanical power seen during the test (1). 
Mean Power: Average mechanical power seen during the test (1). 
Relative Peak Power (Anaerobic Power): Measure of anaerobic power. Peak power 
relative to the subject’s body weight. Expressed in Watts/kilogram (1). 
Relative Mean Power (Anaerobic Capacity): Mean power divided by body weight. 
Measured in watts/kilogram (1). 
Fatigue Index: Peak watts minus minimum watts divided by test duration. Measured in 
Watts/second (1). 
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Chapter 2 
Literature Review 
Introduction 
 The primary purpose of this study is to determine whether 8 weeks of creatine 
supplementation increases exercise performance. The secondary purpose is to determine 
if a combined supplementation of creatine and sodium bicarbonate has an additive effect 
on exercise performance. This literature review will cover the mechanism of creatine and 
sodium bicarbonate and evaluate the current research on the impact of supplementation of 
these on exercise performance.  
Creatine  
Creatine is a non-essential nutrient found naturally in the body (7), which can 
either be ingested or endogenously produced (7). Dietary sources of creatine include 
meat, some fish, and other animal products (61), with a typical dietary intake of creatine 
of approximately 1 gram (61). Endogenously, creatine is formed in the kidney, pancreas, 
and mainly the liver (61).  Creatine is formed from the amino acids glycine, arginine, and 
methionine in a two-step process (61). Arginine and glycine combine to form 
guanidinoacetate (7). Then, a methyl group from S-adenosylmethione is added to form 
creatine (7).  
Nearly all creatine is stored in skeletal muscle with 60% as phosphocreatine (PCr) 
and 40% in the free form (7, 19). Type II muscle fibers tend to have slightly higher levels 
of PCr than Type I fibers (7), most likely due to their reliance on non-oxidative 
metabolism. Thus, phosphocreatine utilization during high-intensity exercise is higher in 
Type II fibers than in Type I fibers (22, 53, 56) 
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Creatine plays an important role in energy metabolism. When energy demand is 
increased, phosphocreatine (PCr) donates its phosphate to adenosine diphosphate (ADP) 
to produce adenosine triphosphate (ATP) (46). This reaction can be summarized as: PCr 
+ ADP + H+à Cr+ATP. This rapid method of producing energy is called the ATP-PCr 
system. This system is used by short-duration, high intensity activities like running, 
cycling, and swimming sprints and weight lifting.  
As the body tries to maintain performance during high intensity activities, the PCr 
stores become depleted. As PCr is depleted, there is a reduction in the rate of ATP 
produced by the ATP-PCr system resulting in a decline in performance (46). Creatine 
monohydrate, taken as a supplement, has been shown to increase total creatine and 
creatine phosphate (4, 22, 24, 26, 58). Supplementation with creatine increased muscle 
PCr concentration up to 20% (55). Increasing muscular creatine levels may improve 
performance by aiding in the rephosphorylation of ADP to ATP, enhancing cross bridge 
cycling and maintenance of tension, and buffering changes in pH (7). 
Creatine Supplementation 
Many studies have examined the effects of short-term (<10 days) creatine 
supplementation on high-intensity, short duration, anaerobic activities such as cycling 
and running sprints (16, 17, 22, 24, 25). 
Aaserud et al (2) and Skare et al (52) both examined the effects of short-term 
creatine supplementation on repeated running sprints. Aaserud et al (2) examined the 
effect of 5 days of creatine supplementation (15g/day) on repeated running sprints. Eight 
maximal sprints of 40 meters with 25 seconds of rest in between were performed. 
Supplementation resulted in a significant (p<0.05) improvement in sprint times in sprints 
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4,6,7, and 8.  Skare et al (52) studied the effect of 5 days of creatine supplementation 
(20g/day) on repeated running sprint performance. One 100m sprint and six 60m sprints 
were performed. Supplementation with creatine significantly (p<0.02) decreased time to 
complete the 100m sprint and significantly (p<0.01) decreased total sprint time of the six 
sprints. Taken together, these studies indicate that short term supplementation with 
creatine can delay onset of fatigue and improve sprint times in runners.  
Several studies have examined the effect of short-term creatine supplementation 
on repeated cycle ergometer sprints. Balsom et al (4) studied the effect of 6 days of 
creatine supplementation (20 g/day) on repeated cycle sprints. Five, 6-second sprints at 
140 rpm with 30-second recovery periods were performed. Following a 40 second rest 
period, after the last sprint, resistance was increased by 5% and subjects were asked to 
maintain 140 rpm for another 10 seconds.  The percent decline in performance was 
significantly (p<0.05) less in creatine supplementation, compared to placebo. Ziegenfuss 
et al (62) studied the effect of 0.35g/kg (fat free mass) of creatine, compared to placebo, 
for 3 days on repeated sprints on a cycle ergometer. Subjects were randomly assigned to a 
placebo group or creatine supplementation group. Subjects performed six 10-second 
sprints with 60 seconds of rest between each sprint. Peak power (watts) in the creatine 
group was significantly (p<0.01) higher than in the placebo group. Birch et al (8) studied 
the effect of 5 days of creatine supplementation (20g/day) on isokinetic repeated cycle 
sprints. Subjects were asked to perform three sprints of 30 seconds with four minutes of 
passive recovery. Supplementation with creatine, compared to placebo, significantly 
(p<0.05) increased peak power output (watts) during sprint one and significantly (p=0.05) 
increased mean power output (average watts) in sprints one and two. Taken together, 
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these studies indicate that short-term supplementation with creatine improves 
performance in cycling sprints. 
Despite the well-documented effects of creatine supplementation increasing 
exercise performance, most studies (including the studies listed above) have used higher 
doses for a short period of time (<7 days). Higher doses of creatine may cause 
gastrointestinal distress such as nausea, vomiting, and diarrhea, which may impair or 
hinder exercise performance (10). Thus athletes need an optimal way to ingest creatine 
supplementation to increase exercise performance and minimize side effects.  
Surprisingly, few exercise studies have evaluated long-term (>3 weeks) creatine 
supplementation on exercise performance. Rawson et al (49) examined the effects of 6 
weeks of low dose (1.7-2.9 g/day) creatine, compared to placebo, on strength training. 
Subjects performed a 3-repetition maximal concentric knee extension with 60 seconds of 
rest to measure maximal strength. Subjects were also asked to perform 5 sets of 30 
concentric knee extensions with 60 seconds of rest between each set to measure muscle 
fatigue. Creatine supplementation, compared to placebo, significantly (P<0.05) increased 
plasma creatine concentrations and increased significantly (p<0.05) resistance to fatigue 
(Nm). Burke et al (11) studied the effects of 21 days of supplementation with ~7.7g/day 
of creatine on strength training. Subjects followed a specific exercise program using free 
weights and completed a maximal concentric bench press and rowing to exhaustion 
before and after supplementation (or placebo). Creatine supplementation, relative to 
placebo, significantly (p<0.05) increased peak force (23% vs. 13%) and significantly 
(p=0.05) increased power output (21% vs. 12%). Time to fatigue was significantly 
(p<0.05) increased and number of repetitions until exhaustion were significantly (p=0.05) 
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increased in the creatine group versus placebo groups (17 to 24 vs. 19 to 20 reps, 
respectively). These studies indicate that long-term (>3 weeks) supplementation with 
creatine increases plasma creatine levels, resistance to fatigue, and power output in 
resistance exercise. No studies have examined the effect of long-term (>3 weeks), low-
dose creatine supplementation on exercise performance, which may lower gastrointestinal 
distress and other potential side effects.  
In review, the available literature suggests: 
• Increased creatine levels, theoretically, improve performance by aiding in the 
rephosphorylation of ADP to ATP, enhancing cross bridge cycling and 
maintenance of tension, and buffering changes in pH (46).  
• Short term supplementation with creatine increases exercise performance and 
reduces fatigue in short term, high intensity activities like running and cycling 
sprints. 
• Long-term supplementation with creatine increases performance and reduces 
fatigue in resistance exercise however; it is unclear whether cycling exercise is 
affected. 
Sodium Bicarbonate  
The body maintains acid-base balance through three mechanisms: chemical 
buffers, the pulmonary system, and the kidneys (37). Buffers minimize changes in 
hydrogen ion concentration by accepting or releasing hydrogen ions (35). Bicarbonate is 
one of the body’s most important buffer systems. The reaction of hydrogen ions with 
plasma bicarbonate results in carbonic acid and carbon dioxide, which is expelled 
through the lungs (35). An increase in extracellular bicarbonate raises the extracellular 
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pH, which promotes hydrogen ion and lactate efflux from muscles, reducing interference 
with ATP production and the contractile process (50).  As the bicarbonate store is 
depleted, buffering ability is reduced and hydrogen ion concentration will increase, 
resulting in a decline in performance (35).  
Moderate to high intensity exercise produces disturbances in the acid-base 
balance due to an increase in hydrogen ions. Increases in hydrogen ions can be attributed 
to: increased production of carbon dioxide, the break down of ATP, and the production of 
lactic acid and lactate (46). Hydrogen ions can hinder performance by altering the size 
and shape of molecules (46). Enzymes needed for ATP production can be affected by this 
change in size and shape and as a result, the muscle cell’s ability to produce ATP is 
reduced (46). In addition, hydrogen ions compete for binding sites with calcium, 
disturbing contraction and lowering force production (46). There must be balance 
between the formation and removal of hydrogen ions for the body to maintain 
homeostasis (38).  
Sodium Bicarbonate Supplementation 
Several studies have examined the effect of short-term and long-term 
supplementation of sodium bicarbonate (15, 36). Lavender and Bird (33) studied the 
effects of short-term sodium bicarbonate supplementation on repeated cycling sprints. 
Sodium bicarbonate supplementation, compared to placebo, 60 and 120 minutes prior to 
exercise resulted in a significantly (p<0.05) higher average power output in 8 out of 10 
sprints and a significantly (p<0.02) higher peak power output in 2 out of 10 sprints. 
Higgins et al (27) also examined the effects of short-term sodium bicarbonate 
supplementation on cycling. Sodium bicarbonate supplementation, compared to placebo, 
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significantly increased exercise capacity at 100% peak watts (p<0.02). McNaughton et al 
(37) studied the effects of 0.5g/kg body mass of sodium bicarbonate, compared to 
placebo, for 5 days on 60 seconds of intense exercise on a cycle ergometer. Peak power 
was significantly (p<0.05) higher in the sodium bicarbonate supplement group versus 
placebo (799+ 23.4 vs. 711 + 19.1). Moreover, Price et al (47) investigated the effects of 
sodium bicarbonate (0.3g/kg) ingested one-hour prior to exercise on maximal cycle 
sprints. Power output was significantly greater (p<0.05) in the sodium bicarbonate group 
compared to placebo. These studies indicate ingesting sodium bicarbonate 60-120 
minutes prior to cycling exercise increases performance.  
While most studies on sodium bicarbonate have investigated its effects on 
cycling, Gao et al (20) studied the effect of sodium bicarbonate supplementation (2.9 
mmol/kg 60 minutes before exercise) on swimming sprints. Subjects were asked to 
perform five 100-yard swim sprints with two-minute rests in between. Sodium 
bicarbonate supplementation resulted in a significant (p<0.05) improvement in sprints 4 
and 5. 
Surprisingly, only one study has examined the effect of long-term (>3 weeks) 
sodium bicarbonate supplementation on exercise performance. Edge et al (18) studied the 
effect of 8 weeks of sodium bicarbonate ingestion during interval training on muscle 
buffer capacity and short-term endurance capacity. Sodium bicarbonate supplementation 
group, compared to placebo, had significantly (p=0.05) greater improvements in lactate 
threshold (26% vs. 15%) and improvements in time to fatigue (164% vs. 123%, P<0.05). 
This study indicates that long-term sodium bicarbonate use could be beneficial but more 
research needs to be completed. 
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Sodium bicarbonate supplementation has been demonstrated to increase exercise 
performance. However, large doses are known to cause gastrointestinal distress, which 
may hinder or impair exercise performance (27, 50). The long-term (>3 weeks) effects of 
a low dose sodium bicarbonate supplement remain unclear, but data from pharmaceutical 
drug studies suggest that ~1g of sodium bicarbonate increases absorption and 
bioavailability. Nuerenberg and Brune (41) studied the effect of adding 1g of sodium 
bicarbonate to medication. Results showed that the addition of sodium bicarbonate 
enhanced absorption due to the increased gastric pH. Banerjee et al (5) also investigated 
the effects of sodium bicarbonate on drug absorption. Results showed that the sodium 
bicarbonate protected the medication against acid degradation of the drug by increasing 
gastric pH. 
In review, the available literature suggests: 
• Supplementation with sodium bicarbonate is theorized to improve 
performance by increasing buffering capacity by reducing the interference 
of hydrogen ions on ATP production and the contractile process. 
• Supplementation with sodium bicarbonate 60-120 minutes before exercise 
results in increased exercise performance. 
• One study showed that long-term supplementation with sodium 
bicarbonate also results in increased exercise performance. 
• Sodium bicarbonate has been shown to increase absorption and speed up 
transport of certain medications. 
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Combined Creatine and Sodium Bicarbonate 
Interestingly, only two published studies have examined the effects of combined 
creatine and sodium bicarbonate supplementation. Mero et al (39) studied the effects of 
combined creatine and sodium bicarbonate supplementation on 100m swimming 
performance. Subjects performed two 100m freestyle swims with 10 minutes of recovery 
between each swim. Supplementation included 20g/day for 6 days of creatine and 0.3g/kg 
of body weight of sodium bicarbonate on the day of testing. Creatine plus sodium 
bicarbonate, supplementation compared to placebo, significantly (p<0.05) decreased 100-
meter swim time. However, there was no creatine only or sodium bicarbonate only 
condition, so the true effectiveness of combined supplementation is not known.  Barber et 
al (6) examined the effect of combined creatine and sodium bicarbonate supplementation, 
compared to placebo and creatine alone, on repeated cycling sprint performance. Subjects 
completed six 10-second Wingate sprints with 60 seconds of rest between each sprint. 
Combined creatine and sodium bicarbonate supplementation, compared to placebo, 
significantly (p=0.002) increased peak power and mean power in repeated cycling 
sprints. Also, creatine plus sodium bicarbonate had the slowest rate of decline in peak 
power in the 6 springs.  Taken together, these data suggest that combined creatine and 
sodium bicarbonate supplementation may have an additive effect on performance. 
However, no published study has examined the long-term (>3 weeks) effects of these two 
supplements. 
5-K Time Trial 
Studies on creatine supplementation with exercise lasting longer than two minutes 
are limited. Additionally, only one study has examined the effects of creatine 
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supplementation on a cycling time trial (58). However, the ergometer (Velotron Dynafit 
Pro cycle ergometer, RacerMate Inc, Seattle, WA, USA) that we had access to was not 
used in that study. Jacobs et al (32) studied the effect of Sildenafil on 6-km time trial 
performance using the Velotron cycle ergometer. One hour before exercise, subjects 
ingested either placebo or 50 mg of sildenafil in a randomized, counterbalanced fashion. 
After a 5 minute warm up, subjects were instructed to complete a 6-K time trial as fast as 
possible and received no feedback other than when they were half way. Subjects were 
allowed to change gears to alter resistance. Therefore their speed and power output were 
a function of the resistance they selected and their RPM (32). Results indicated that 
Sildenafil versus placebo did not have an effect on exercise performance (time to 
completion, mean power output)(32).  
Conclusion 
Creatine and sodium bicarbonate are two of the most tested ergogenic aids. Many 
studies on both creatine and sodium bicarbonate have been short term, high dose studies. 
The findings are generally robust for short term, high doses. These studies suggest that 
both creatine and sodium bicarbonate independently have a positive effect on short 
duration, high intensity exercise. Less research has been completed on long term, low 
doses of creatine and sodium bicarbonate. The few studies that have focused on longer 
supplementation have indicated that lower doses over a long period of time work just as 
well as a shorter loading period. Additionally, long-term supplementation may be 
preferred by athletes to avoid the common side effects of high doses of both creatine and 
sodium bicarbonate. 
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Chapter 3 
Methods 
Overview 
The effects of 8 weeks of creatine supplementation and creatine plus sodium 
bicarbonate supplementation on exercise performance were assessed in adult men and 
women.  Using a randomized, double-blinded, study design, subjects were assigned to 
one of three conditions for eight weeks: 1) placebo, 2) creatine supplement alone, 3) 
creatine plus sodium bicarbonate supplement.  Exercise performance, perceptions of 
fatigue and gastrointestinal distress were assessed before and after each condition.  
Subjects 
Sixty-three healthy, habitually active men and women were recruited from 
California Polytechnic State University and the surrounding area (Table 1). Inclusion 
Criteria included: (1) 18 to 40 years old, (2) body mass index (BMI) of 18.5 to < 35, (3) 
non-smoking, (4) > 2 hours of weekly physical activity, (5) VO2Peak > 30ml/kg*min (6) 
free of any chronic or metabolic disease as assessed by a Health History Questionnaire, 
and (7) no current use or use in the past 3 months of creatine, sodium bicarbonate, or any 
other dietary supplement. Exclusion Criteria includes: (1) history of infertility, (2) 
pregnant or trying to become pregnant, (3) Type I or II diabetes, (4) cardiovascular 
disease or any other metabolic disease/complication, (5) more than 3 kg of weight loss in 
the last 6 months, (6) history of bariatric surgery, (7) major medical conditions that 
prohibit physical activity, and (8) extreme diets (eg. Paleo diet, Atkins) that may 
influence performance.  Subjects were informed of the requirements, risks, and benefits 
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of the study. The Human Subjects Committee at Cal Poly approved this study, and all 
subjects gave verbal and written consent.  
Variables 
N = 63 
(M 28, F 35) 
P 
N = 20 
(M 8, F 12) 
Cr 
N = 21 
(M 10, F 11) 
CrSb 
N = 22 
(M 10, F 12) 
p-value 
Age (yr) 23+3.6 21+0.7 22 + 1.2 0.06 
Height (cm) 170.5+9.3 172.8+9.7 172.1+9.4 0.73 
Weight (kg) 69.3+11.2 69.7+15.8 70.2+14.5 0.98 
BMI  23.8+3 23.1+3.6 23.4+2.9 0.83 
VO2 Peak 42.1+9.3 42.2+5.8 40+7.9 0.61 
Table 3-1. Subject Characteristics. Values are mean + SD. P= Placebo, Cr= Creatine, 
CrSb = Creatine and Sodium Bicarbonate.  
 
Preliminary Tests 
Subjects completed a Health History Questionnaire, a 7-day physical activity recall, and 
the Physical Activity Readiness Questionnaire (PAR-Q) (See appendices A, B, D).  
Subjects then completed a VO2Peak test using the Astrand protocol (25).  Briefly, after a 5-
minute warm-up, workload on a cycle ergometer (Quinton Cycle Ergometer, Lode B.V., 
Griningen, Holland) was increased 50 W every 3 minutes for men and 30 W every 3 
minutes for women. During the test, oxygen consumption and carbon dioxide production 
were assessed using an online metabolic system (Parvomedics TrueMax 2400, 
Consentius Technologies, Sandy, UT), and VO2 Peak was defined as the highest VO2 value 
obtained (30 second average). Termination criteria included 3 out of 4: (1) respiratory 
exchange ratio  > 1.15, (2) heart rate within 10 beats of age predicted heart rate max (220 
– age), (3) the subject voluntarily stopped the test, and 4) RPE>18. Subjects were asked 
to complete the test again at another date if they did not meet three of these conditions.  
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Exercise Protocol 
All subjects completed 6 exercise tests (2 practice, 2 baseline, 2 post-supplement).  The 
practice trials of the repeated sprint test and time-trial test were selected to minimize any 
learning effects of the exercise protocols (see below for description of exercise tests).  
Subjects completed the practice and baseline exercise tests first, and then were randomly 
assigned to one of the three conditions (see Supplement Procedure below) for 8 weeks. 
The final exercise test was completed after the 8 weeks of supplementation.  
  Subjects were asked to refrain from exercise, alcohol, and caffeine for 24 hours 
prior to testing.  After a 12-hour overnight fast, subjects arrived in the morning in the 
Kinesiology Department and completed either a repeated sprint test or time-trial test, in a 
counterbalanced order.  There was a minimum of 48 hours between exercise tests.   
Repeated Sprint Test 
Subjects performed a modified Wingate test (6x10second sprints) on a Velotron 
Dynafit Pro cycle ergometer (Racer-Mate Inc, Seattle, WA, USA), as previously used in 
the kinesiology laboratory (6). This test consists of six 10-second sprints with a 60-
second active recovery after each sprint. The test started with a 5-minute warm-up at 50 
W with three 5-second practice sprints. At the end of the warm-up, the test administrator 
gave a 10- second countdown in which subjects built up their maximal effort. At the end 
of the countdown, resistance equal to 0.075 kg per kilogram of body weight was 
magnetically added at the beginning of the sprint (31, 62). Subjects were instructed to 
perform maximally throughout each sprint. No feedback or encouragement was given. 
Immediately following each sprint, there was a 60-second active recovery at 50W. This 
procedure was repeated six times.  Performance measures assessed include: Primary 
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Measures: peak power (W), mean power (W); Secondary Measures: relative peak power 
(W/kg), relative mean power (W/kg), and fatigue index (W/second).  
Gastrointestinal distress was assessed before and after the test using a validated 
questionnaire (44).  The questionnaire addresses upper abdominal problems, lower 
abdominal problems and systemic discomfort. Each question is rated on a 0 – 10 point 
scale that ranged from 0 = no problem at all to 10 = the worst it has ever been (See 
Appendix C). Perceived level of exertion was assessed using the Borg Ratings of 
Perceived Exertion (RPE) scale before and after each sprint (9, 40).  
Time Trial Test 
 Subjects completed a 5-kilometer time trial test as previously described by Jacobs 
et al (32). Subjects warmed up for 5 minutes prior to the time-trial.  Using a gated-style 
start, subjects remained motionless on the time-trial bike (Velotron Dynafit Pro cycle 
ergometer, RacerMate Inc, Seattle, WA, USA) until the test was initiated by the 
researcher.  The subjects were allowed to change gears as often as desired to simulate 
actual outdoor racing and were instructed to complete the 5 km time-trial as quickly as 
possible.   Subjects were not allowed to view their time, watts, speed, or distance on the 
monitor.  They were informed when they completed half of the distance but were given 
no other feedback. RPE and heart rate were recorded at the halfway point and in the last 
minute.  
 Performance measures assessed include: Primary Measure: time to completion; 
Secondary Measures: max watts, average watts, max speed, average speed, heart rate, 
average rpm, and max rpm. Subjects also completed the gastrointestinal distress 
questionnaire before and after the time trial.  
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Supplementation Procedure 
 After the familiarization trial and baseline tests were completed, subjects were 
randomly assigned (by sex) to a placebo (P), creatine only (Cr), or creatine plus sodium 
bicarbonate supplement (CrSb), in a double-blind fashion, for 8 weeks. The placebo was 
a calcium pill (Costco Wholesale Corporation, Seattle, WA.). Calcium was chosen as a 
placebo because current research suggests that carbohydrates, or a sugar pill, even in the 
form of a mouth rinse, have a positive effect on exercise performance (13, 45). The 
creatine supplement (Now Sports, Bloomingdale, IL) consisted of 3 grams per day, as 
recommended by the American College of Sports Medicine (55). The creatine plus 
sodium bicarbonate supplement consisted of 3 grams of creatine plus 1 gram of sodium 
bicarbonate (Church & Dwight Co. Inc., Princeton, NJ). Subjects were asked to take their 
assigned pills everyday, in the morning with food and their adherence and GI distress was 
recorded using a weekly pill log. Subjects were given one week worth of pills and at the 
end of each week met a researcher in the kinesiology lab to get new pills for the next 
week. Subjects were reminded to take pills 3 to 4 times a week via phone call or text 
message. At the end of 8 weeks, subjects were asked to take their pills one hour prior to 
exercise testing.  
Statistical Analysis 
 JMP by Statistical Analysis Software Inc. (SAS Institute, Cary, North Carolina) 
was used for data analysis. For the Wingate sprint test, slope (rate of decline) for each 
performance measure over the six sprints was determined by calculating the individual 
slope for each subject through a regression analysis. Slope was calculated for each 
performance measure, both pre and post supplementation. A repeated measures ANOVA 
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was used to determine treatment, sprint, and treatment by sprint interactions for peak 
power, relative peak power, mean power, relative mean power, and fatigue index. Sex, 
VO2 Peak, and BMI were used as covariates. Moreover, general linear model was used to 
determine differences in individual sprints. For the time trial data, a repeated measures 
ANOVA was used to determine treatment and treatment by time interactions using the 
same covariates. By convention, α <0.05 was considered significant and when significant, 
Tukey’s Honestly Significant Difference test was used to determine where the difference 
lied. In exploratory analyses, paired t-tests were used to determine differences within 
groups over time. Statistical analyses used intent-to treat analysis (i.e. baseline data was 
carried forward) when subjects were lost to follow up. Two subjects dropped out before 
finishing the second round of testing.  
Sample Size Calculation 
In conducting our power analysis (N=60) we assumed intent to treat analyses and 
that 5% would be lost to follow up.  
Primary Hypothesis: The power calculation and sample size for this study is based 
on a study by Burke et al. (2000) that found a significant increase (p<0.05) in total work 
in low dose creatine supplementation versus placebo (68% vs. 16%).  Using a similar 
small to moderate effect size, a sample size of 57 (19 in each group) would have 93.5% 
power to detect a significant difference in creatine versus placebo using an α = 0.05 and a 
two-sided test of significance. 
Secondary Hypotheses: Relative peak power (Watts/kg body weight) during the 
repeated sprint exercise test was used to calculate the effect size and determine the 
necessary sample size, because relative peak power is a critical marker of exercise 
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performance. The calculation is based on a previous study by Barber et al (2012) showing 
a significant increase in relative peak power after creatine plus sodium bicarbonate 
supplementation vs. placebo (13.5 ± 1.0 vs. 12.5 ± 1.0 watts/kg body weight).  Using a 
similar small to moderate effect size, a sample size of 57 (19 in each group) would have 
86.9% power to detect a significant difference in relative peak power with the creatine 
plus sodium bicarbonate supplement vs. placebo using an α = 0.05 and a two-sided test of 
significance.   
  Barber et al (6) also showed a significant difference in relative peak power after 
creatine plus sodium bicarbonate supplementation vs. creatine only supplementation 
(1.5+1.0 vs. 0.6± 1 watts/kg body weight).  Using a similar small to moderate effect size, 
a sample size of 57 (19 in each group) would have 85.2% power to detect a significant 
difference in relative peak power with the creatine plus sodium bicarbonate supplement 
vs. creatine only supplement using an α = 0.05 and a two-sided test of significance.  
Limitations 
No blood analyses were completed in this study. Therefore, we cannot conclude if the 
low doses of creatine and sodium bicarbonate actually increased serum levels. Subjects 
were expected to follow the supplementation protocol. Subjects were required to return 
pill containers weekly and report to a research assistant. However, since they were not 
monitored daily, we can’t be sure how well they adhered to the supplementation protocol. 
In addition, maximal effort may vary by person and we cannot be sure that subjects were 
giving maximal effort during the exercise tests.  
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Chapter 4 
Results 
Wingate Repeated Sprint Test 
Peak Power 
There was a significant interaction of treatment * time (p = 0.035) in peak power 
slope between the three groups. The slope (rate of decline) in the placebo group and 
creatine and sodium bicarbonate group was significantly worse (p = 0.03 and p = 0.025 
respectively) than the slope (rate of decline) in the creatine group (Figure 4.1). There was 
no significant (p = 0.94) difference in slope (rate of decline) between the placebo group 
and creatine and sodium bicarbonate group.  
There was no significant difference in placebo or creatine across sprints. A 
general linear model was used to compare differences in individual sprints. Peak power 
output was significantly lower (p<0.05) in sprint 4, 5, and 6 compared to sprint 1 in the 
creatine and sodium bicarbonate group (Table 4-1).  
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Figure 4.1. Peak Power Slope in the Three Groups. P = placebo group, Cr = creatine 
group, CrSb = creatine and sodium bicarbonate group; Pre = before 8 week 
supplementation, Post = after 8 week supplementation. * Cr is significantly higher than P 
and CrSb 
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Relative Peak Power  
 There was no significant difference (p= 0.15) in rate of decline (slope) between 
the three groups (Figure 4.2). Moreover, using a general linear model, there was no 
significant difference within or between groups in relative peak power (Table 4-1).  
In exploratory analysis, placebo (p=0.009) and creatine and sodium bicarbonate (p 
=0.04) slope (rate of decline) was significantly worse from pre to post. There was no 
significant difference (p = 0.26) in creatine slope (rate of decline) from pre to post.  
 
Figure 4.2. Relative Peak Power Slope in the Three Groups. P = placebo, Cr = Creatine, 
CrSb = Creatine and Sodium Bicarbonate; Pre = before 8 week supplementation, Post = 
after 8 week supplementation. * Placebo post slope significantly worse (p = 0.009); 
Creatine and Sodium Bicarbonate post slope significantly worse (p = 0.04). 
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Mean Power 
 
There was no significant difference (p=0.18) in slope (rate of decline) between the 
three groups in mean power (Figure 4.3). Using a general linear model, to examine 
differences across sprints within groups, mean power was significantly lower (p<0.05) in 
the creatine and sodium bicarbonate group in sprint 4, 5, and 6 compared to sprint 1 
(Table 4-1).  Moreover, mean power was significantly lower (p<0.05) in sprint 6 
compared to sprint 1 in placebo (Table 4-1).  
In exploratory analysis, the placebo group (p=0.0008) and the creatine and 
sodium bicarbonate group (p =0.001) slope (rate of decline) was significantly worse from 
pre to post. There was no significant difference (p = 0.43) in slope (rate of decline) from 
pre to post in the creatine group.  
 
 
Figure 4.3. Mean Power Slope in the Three Groups. P = placebo group, Cr = creatine 
group, CrSb = creatine and sodium bicarbonate group; Pre = before 8 week 
supplementation, Post = after 8 week supplementation. *P post slope significantly worse 
(p=0.0008); CrSb post slope significantly worse (p=0.001). 
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Relative Mean Power 
There was no significant difference (p=0.15) in slope (rate of decline) between the 
three groups in relative mean power (Figure 4.4). Using a general linear model, to 
examine differences across sprints within group, the creatine and sodium bicarbonate 
group and placebo group showed significantly lower (p<0.05) power output values in 
sprint 4, 5, and 6 compared to sprint 1 (Table 4-1).   
In exploratory analysis, placebo (p=0.002) and creatine and sodium bicarbonate 
groups (p =0.004) slope (rate of decline) was significantly worse from pre to post. There 
was no significant difference (p = 0.44) in the creatine group slope (rate of decline) from 
pre to post. 
 
 
Figure 4.4. Relative Mean Power Slope in the Three Groups. P = placebo group, Cr = 
creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 8 week 
supplementation, Post = after 8 week supplementation.*P post slope significantly worse 
(p = 0.002); CrSb post slope significantly worse (p = 0.004). 
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Fatigue Index 
There was no significant difference (p=0.14) in slope (rate of decline) in fatigue 
index (Figure 4.5). Using a general linear model, there was no significant (p>0.05) 
difference within groups in fatigue index (Table 4-1). 
In exploratory analysis, fatigue index was not significantly different in placebo 
and creatine and sodium bicarbonate pre to post (p = 0.2 and p = 0.6 respectively). 
However, fatigue index was significantly higher (p = 0.03) from pre to post in the 
creatine group.  
 
 
Figure 4.5. Fatigue Index in the Three Groups. P = placebo group, Cr = creatine group, 
CrSb = creatine and sodium bicarbonate group; Pre = before 8 week supplementation, 
Post = after 8 week supplementation.*Cr post slope significantly higher (p = 0.03). 
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Rate of Perceived Exertion 
There was a main effect for treatment (p < 0.001), time (p < 0.001) and 
interaction of treatment * time (p<0.001). Placebo group RPE post supplementation was 
significantly higher (p<0.001) than RPE in the pre supplementation condition. RPE was 
significantly higher in the creatine (p=0.03) and creatine and sodium bicarbonate groups 
(p =0.002) during pre and post conditions. However, there were no significant (p>0.05) 
differences within those groups from pre to post supplementation.  
 
Gastrointestinal Distress Questionnaire  
There was no significant main effect of treatment for any of the questions. The 
creatine group showed a significant decrease in nausea (p=0.007) and muscle cramps (p = 
0.02) from pre to post. The creatine and sodium bicarbonate group showed a significant 
increase in nausea (p=0.002) and muscle cramps (p=0.02) from pre to post. The placebo 
group showed a significant increase in nausea (p = 0.04) from pre to post. Other 
gastrointestinal distress questions were not significant (p>0.05). Individual values are 
shown in Table 4-2. 
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Variable Sprint Placebo Creatine Creatine + Sb 
Peak Power 
(W) 
1 
2 
3 
4 
5 
6 
738+176 
720 + 166 
720 + 160 
692 + 166 
688+ 171 
687+ 152 
836 + 289 
796 + 260 
790+ 281 
781+ 265 
779+ 256 
776+ 246 
806 + 221 
794 + 206 
774+ 233 
743 + 214* 
735 + 213* 
719 + 200* 
Relative Peak 
Power 
(W/kg) 
1 
2 
3 
4 
5 
6 
10.6 + 1.5 
10.3 + 1.4 
10.3 + 1.2 
9.9 + 1.4 
9.8 + 1.4 
9.8 + 1.3 
11.6 + 1.6 
11 + 1.4 
10.9 + 1.6 
10.8 + 1.4 
10.8 + 1.3 
10.8 + 1.3 
11.2 + 1.8 
10.9 + 1.5 
10.8 + 1.4 
10.3 + 1.3 
10.2 + 1.3 
10 1. + 2 
Mean Power 
(W) 
1 
2 
3 
4 
5 
6 
663 + 160 
640 + 155 
640 + 151 
608 + 155 
606 + 160 
604 + 147* 
740 + 239 
710 + 215 
684 + 210 
668 + 190 
656 + 176 
660 + 180 
727 + 202 
707 + 193 
675 + 201 
649 + 184 * 
637 + 183 * 
630 + 177 * 
Relative Mean 
Power 
(W/kg) 
1 
2 
3 
4 
5 
6 
9.5 + 1.5 
9.2 + 1.4 
9.2+ 1.4 
8.7 + 1.5* 
8.7 + 1.5* 
8.7 + 1.5* 
10.3 + 1.4 
9.9 + 1.3 
9.5 + 1.3 
9.3 + 1.1 
9.1 + 1.1 
9.2 + 0.99 
10.1 + 1.7 
9.8 + 1.5 
9.4 + 1.4 
9.1 + 1.2* 
8.9 + 1.2* 
8.8 + 1.2* 
Fatigue Index 
(W/s) 
1 
2 
3 
4 
5 
6 
17.4 + 14.1 
21.4 1 + 8.1 
18.5  + 14.5 
18.4  + 15.1 
19.1  + 13.9 
19.2  + 14.1 
21.6  + 15.1 
20.1  + 14.7 
22.8  + 19.3 
25.5 1 + 9.9 
27.4  + 20.1 
27.9 +  19.8 
18.3 +  6.5 
20.9  + 7.5  
22.4  + 10.9 
21.6  + 12.4 
22.2  + 11 
20.6  + 10.4 
RPE 1 
2 
3 
4 
5 
6 
12.2 + 1.8 
13.5 + 1.9 
14.6 + 1.9 
15.5 + 1.9 
16.2 + 1.6 
16.6 + 1.7 
12 + 1.9 
13.7 + 1.7 
14.9 + 1.5 
16 + 1.5 
16.8 + 1.6 
17.6 + 1.6 
12.1 + 2.2 
13.7 + 1.9 
15.1 + 1.8 
15.8 + 1.8 
16.7 + 1.8 
17.2 + 1.7 
Table 4-1. Mean Values of Variables by Sprint. Values are in means + SD. W = watts, 
W/kg = Watts per kilogram of body mass, W/s = watts per second, RPE = rate of 
perceived exertion. *significantly lower than sprint 1 
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Section/Question Condition Placebo Creatine CrSb 
Upper Abdominal 
1 
 
Pre 
Post 
 
0.10+0.30 
0+0 
 
0.09+0.44 
0+0 
 
0+0 
0.05+0.21 
2 Pre 
Post 
0.05+0.23 
0.10+0.45 
0.09+0.44 
0+0 
0+0 
0.27+0.77 
3 Pre 
Post 
0.05+0.23 
0.05+0.22 
0.14+0.65 
0+0 
0.41+1.33 
0.14+0.47 
4 Pre 
Post 
0.05+0.23 
0.1+0.31 
0.29+1.10 
0.19+0.87 
0.41+1.33 
0.18+0.66 
5 Pre 
Post 
0.40+1.57 
0.20+0.52 
0.24+0.77 
0.09+0.44 
0.27+1.08 
0.50+1.47 
6 Pre 
Post 
0.50+1.57 
1.35+1.79** 
0.76+1.48 
0.29+0.78* 
0.41+0.96 
1.77+2.29** 
Lower Abdominal 
1 
 
Pre 
Post 
 
0.05+0.22 
0.05+0.22 
 
0.14+0.65 
0.14+0.65 
 
0+0 
0.05+0.21 
2 Pre 
Post 
0.30+0.92 
0.10+0.45 
0.14+0.48 
0.09+0.44 
0.36+1.14 
0.24+0.89 
3 Pre 
Post 
0.15+0.49 
0+0 
0.19+0.60 
0.19+0.87 
0.05+0.21 
0.14+0.35 
4 Pre 
Post 
0.05+0.22 
0.10+0.45 
0.14+0.65 
0.14+0.48 
0+0 
0.09+0.29 
5 Pre 
Post 
0.05+0.22 
0+0 
0.14+0.65 
0.05+0.22 
0+0 
0.09+0.29 
6 Pre 
Post 
0.05+0.22 
0+0 
0.05+0.22 
0.09+0.44 
0.05+0.21 
0.14+0.64 
7 Pre 
Post 
0.05+0.22 
0+0 
0.05+0.22 
0+0 
0+0 
0.14+0.47 
Systemic 
1 
 
Pre 
Post 
 
0.50+1.10 
0.90+1.45 
 
0.67+1.49 
0.29+1.10 
 
0.82+1.37 
1+2.02 
2 Pre 
Post 
0.45+0.83 
0.15+0.49* 
0.71+1.35 
0.43+1.21 
0.45+1.06 
0.41+0.96 
3 Pre 
Post 
0.45+0.95 
0.25+0.72 
1.05+2.01 
0.33+1.15* 
0.41+0.96 
0.86+1.55** 
4 Pre 
Post 
0.10+0.32 
0+0 
0.33+0.97 
0.14+0.65 
0.18+0.85 
0.05+0.21 
Table 4-2.  Gastrointestinal Distress Questionnaire Responses (Wingate).  CrSb = 
Creatine and Sodium Bicarbonate. Values are in means + SD. *Post value significantly 
lower than Pre value; ** Post value significantly higher than Pre value 
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Time Trial 
Time to Completion 
There was a significant main effect for treatment (p = 0.02) (Figure 4.6) but no 
significant effect for time or interaction of treatment*time. The creatine group had 
significantly longer (p = 0.01) times than the creatine and sodium bicarbonate group at 
baseline.  
 In exploratory analysis the creatine group showed a significant decrease in time to 
completion (p=0.01). There was no significant improvement in the placebo (p=0.8) or 
creatine and sodium bicarbonate groups(p=0.8).  
 
 
 
Figure 4.6. 5-K Time to Completion in the Three Groups. Values are mean + SEM. P = 
placebo group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = 
before 8 week supplementation, Post = after 8 week supplementation.  * Cr time to 
completion was significantly higher than CrSb (p=0.01). 
$ Cr post time to completion was significantly lower than pre time to completion 
(p=0.01).   
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Mean Speed 
There was a main effect for treatment (p = 0.01), but no effect of time or 
interaction of treatment*time (Figure 4.7). The creatine group had significantly lower (p 
= 0.02) mean speed than the creatine and sodium bicarbonate group at baseline.  
 In exploratory analysis, the creatine group had a significant increase in mean 
speed (p=0.01). Combined creatine and sodium bicarbonate (p = 0.6) and placebo (p=0.6) 
had no significant difference within groups.  
 
 
 
Figure 4.7. 5-K Mean Speed in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 
8 week supplementation, Post = after 8 week supplementation.* Cr had a significantly 
lower mean speed than CrSb (p=0.01)$ Cr post supplementation mean speed is 
significantly higher than pre mean speed (p=0.01). 
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Peak Speed 
There was a significant main effect for treatment (p = 0.04), but no effect of time 
or interaction of treatment*time (Figure 4.8). The creatine group had significantly lower 
(p = 0.04) peak speed than the creatine and sodium bicarbonate group at baseline.  
In exploratory analysis there was no significant difference between pre and post 
supplementation peak speed within any of the groups.   
 
 
Figure 4.8. 5-K Peak Speed in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; KPH = 
kilometers per hour; Pre = before 8 week supplementation, Post = after 8 week 
supplementation. * Cr peak speed significantly lower (p=0.04) than CrSb. 
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Mean Power 
There was a main effect for treatment (p = 0.03), but no effect of time or 
interaction of treatment*time (Figure 4.9).  The creatine group had significantly lower 
(p=0.03) average power than the creatine and sodium bicarbonate group at baseline.  
 In exploratory analysis, the creatine group had a significant increase in mean 
power (p=0.01) pre to post. Combined creatine and sodium bicarbonate and placebo had 
no significant difference within groups between pre and post supplementation mean 
power.  
 
 
Figure 4.9. 5-K Mean Power in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 
8 week supplementation, Post = after 8 week supplementation. *Cr significantly lower 
mean power than CrSb (p=0.03) $ Cr post supplementation mean power is significantly 
higher than pre mean power (p=0.01). 
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Peak Power 
There was no significant main effect of treatment, time or interaction of 
treatment*time (Figure 4.10).  
In exploratory analysis, there was no significant difference between pre and post 
supplementation peak power within any of the groups. 
 
 
Figure 4.10. 5-K Peak Power in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 
8 week supplementation, Post = after 8 week supplementation.  
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Mean RPM 
There was no significant main effect of treatment, time or interaction of 
treatment*time (Figure 4.11).  
In exploratory analysis, the creatine group had a significant decrease in mean 
RPM (p=0.03). Combined creatine and sodium bicarbonate (p = 0.6) and placebo (p=0.1) 
had no significant difference within groups between pre and post mean RPM.  
 
 
Figure 4.11. 5-K Mean RPM in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 
8 week supplementation, Post = after 8 week supplementation. *Cr post supplementation 
mean RPM is significantly lower than pre mean RPM (p=0.03). 
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Peak RPM 
There was no significant main effect of treatment was observed. There was an 
effect of time (p = 0.02) such that post supplementation peak RPM was significantly 
lower than pre supplementation RPM. The interaction of treatment*time was not 
significant (p>0.05) (Figure 4.12).  
In exploratory analysis, the placebo (p = 0.03), creatine (p =0.04), and creatine 
and sodium bicarbonate (p = 0.04) groups all showed a significant decrease in peak RPM 
from pre to post supplementation.  
 
 
Figure 4.12. 5-K Peak RPM in the Three Groups. Values are mean + SEM. P = placebo 
group, Cr = creatine group, CrSb = creatine and sodium bicarbonate group; Pre = before 
8 week supplementation, Post = after 8 week supplementation. * P (p=0.03), Cr (p=0.04), 
and CrSb (p=0.04) post supplementation peak RPM is significantly lower than pre peak 
RPM. 
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Mean Heart Rate 
There was no significant main effect of treatment, time or interaction of 
treatment*time (data not shown). In exploratory analysis, there was no significant 
difference between pre and post supplementation mean heart rate within any of the 
groups. 
Peak Heart Rate 
There was no significant main effect of treatment, time or interaction of 
treatment*time (data not shown). In exploratory analysis, there was no significant 
difference between pre and post supplementation peak heart rate within any of the 
groups. 
Rate of Perceived Exertion 
There was no significant main effect of treatment, time or interaction of 
treatment*time. There was no significant difference in RPE from pre to post in halfway 
point of 5 km time trial (Placebo p = 0.5; Cr p= 0.7; CrSb p = 0.6) or last minute point of 
5 km time trial (Placebo p = 1; Cr p= 0.6; CrSb p = 0.3). All groups had a significantly 
higher (p<0.001) last minute RPE than half-way RPE in both pre and post 
supplementation.  
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Gastrointestinal Distress Questionnaire  
No main effect of treatment was observed for any of the questions. However, 
there was a significant interaction of treatment*time (p=0.012) such that the placebo 
group had a significant increase in nausea (p=0.02) from pre to post. Moreover, the 
creatine and sodium bicarbonate group had a significant increase in loose stool (p = 0.04) 
and diarrhea (p=0.04) from pre to post. There was no significant difference in any 
gastrointestinal distress markers in the creatine group. Other gastrointestinal distress 
questions were not significant (p>0.05). Individual values are shown in Table 4-4.  
 
  
Variable Condition Placebo Creatine CrSb 
Time to 
Completion 
(Min) 
Pre 
Post 
9.63 + 1.28 
9.59 + 1.33 
10.01 + 1.26 
9.69 + 1.33* 
9.52 + 1.36 
9.57 + 1.22 
Mean Speed 
(kph) 
Pre 
Post 
32 + 4 
32 + 4 
30 + 4 
32 + 4* 
32 + 5 
32 + 4 
Peak Speed 
(kph) 
Pre 
Post 
35 + 5 
36 + 6 
35 + 5 
36 + 6 
37 + 7 
35 + 5 
Mean Power 
(W) 
Pre 
Post 
180 + 55 
185 + 66 
164 + 55 
184 + 66* 
196 + 103 
185 + 62 
Peak Power 
(W) 
Pre 
Post 
251 + 84 
258 + 110 
246 + 131 
279 + 138 
304 + 202 
249 + 87 
Mean RPM Pre 
Post 
90.6 + 11.8 
87.6 + 10.63 
90.57 + 12.65 
84.38 + 13.63* 
92+ 11 
91 + 12 
Peak RPM Pre 
Post 
100 + 13 
96 + 12* 
102 + 13 
96 + 11* 
104 + 12 
100 + 12* 
RPE Pre Half Way 
Pre End 
Post Half Way 
Post End 
14 + 2 
16 + 2** 
14 + 2 
16 + 2** 
14 + 2 
16 + 2** 
14 + 2 
16 + 2** 
13 + 2 
16 + 2** 
13 + 2 
16 + 1** 
Table 4-3. Mean Values of Variables by Sprint. Values are in means + SD. W = watts, 
Min = minutes, kph = kilometers per hour, RPE = rate of perceived exertion. * (p<0.05) 
Post value significantly different than pre value. **End RPE significantly different 
(p<0.0001) than Half Way RPE. 
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Section/Question Condition Placebo Creatine CrSb 
Upper Abdominal 
1 
 
Pre 
Post 
 
0.05+0.22 
0.10+0.31 
 
0.26+0.89 
0.05+0.22 
 
0.05+0.21 
0+0 
2 Pre 
Post 
0.05+0.22 
0+0 
0.09+0.44 
0.05+0.22 
0.05+0.21 
0.14+0.64 
3 Pre 
Post 
0.15+0.37 
0.05+0.22 
0.31+1.05 
0.05+0.22 
0.27+0.70 
0.23+0.69 
4 Pre 
Post 
0.10+0.45 
0.10+0.45 
0.29+1.31 
0.19+0.87 
0.14+0.35 
0.27+0.77 
5 Pre 
Post 
0.05+0.22 
0.10+0.45 
0.09+0.44 
0+0 
0.09+0.29 
0.05+0.21 
6 Pre 
Post 
0.05+0.22 
0.60+1.14** 
0.24+0.77 
0.05+0.22 
0.41+1.05 
1.77+2.29 
Lower Abdominal 
1 
 
Pre 
Post 
 
0.05+0.22 
0.05+0.22 
 
0.09+0.44 
0.14+0.48 
 
0+0 
0+0 
2 Pre 
Post 
0.40+1.35 
0.15+0.49 
0.19+0.68 
0.09+0.44 
0.23+1.07 
0.18+0.85 
3 Pre 
Post 
0.05+0.22 
0.05+0.22 
0.05+0.22 
0.05+0.22 
0+0 
0.50+2.13 
4 Pre 
Post 
0.05+0.22 
0.05+0.22 
0.14+0.65 
0.05+0.22 
0+0 
0+0 
5 Pre 
Post 
0.05+0.22 
0.05+0.22 
0.14+0.65 
0.14+0.48 
0.05+0.21 
0.09+0.43 
6 Pre 
Post 
0+0 
0+0 
0.09+0.44 
0+0 
0+0 
0.27+0.70** 
7 Pre 
Post 
0+0 
0+0 
0.05+0.22 
0+0 
0+0 
0.23+0.61** 
Systemic 
1 
 
Pre 
Post 
 
0.35+0.75 
0.45+0.89 
 
0.33+0.97 
0.29+0.90 
 
0.64+1.53 
0.45+1.01 
2 Pre 
Post 
0.35+0.75 
0.30+0.73 
0.33+1.15 
0.19+0.68 
0.45+1.18 
0.14+0.64 
3 Pre 
Post 
0.65+1.09 
0.35+0.99 
0.24+0.89 
0.43+1.12 
0.73+1.42 
0.68+1.46 
4 Pre 
Post 
0+0 
0+0 
0.24+0.89 
0.09+0.44 
0+0 
0+0 
Table 4-4. Gastrointestinal Distress Questionnaire Responses (5-K). Values are in means 
+ SD. ** Post value significantly higher than Pre value. 
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Chapter 5 
Discussion 
The primary purpose of this study was to determine whether 8 weeks of low-dose 
creatine supplementation increased exercise performance. The secondary purpose was to 
determine if a combined supplementation of creatine and sodium bicarbonate had an 
additive effect on exercise performance. The main findings of this study were: 1) creatine 
supplementation, compared to placebo and creatine and sodium bicarbonate, improved 
peak power output slope (rate of decline) in repeated sprints, 2) in exploratory analyses, 
placebo and creatine and sodium bicarbonate supplementation, had worse mean power 
and relative mean power output slopes (rate of decline) in repeated sprints, 3) in 
exploratory analyses, creatine supplementation improved time to completion, increased 
speed, and increased mean power output during the 5-km time trial and 4) creatine 
supplementation reduced nausea and cramping, whereas placebo and creatine and sodium 
bicarbonate supplementation did not. However, in contrast to our hypothesis, we noted no 
additive effect of sodium bicarbonate to creatine supplementation. These data suggest 
that 8 weeks of low dose creatine supplementation improves exercise performance while 
minimizing gastrointestinal distress but adding sodium bicarbonate supplementation to 
creatine offers no beneficial effect.   
In general, creatine supplementation is well established to improve exercise 
performance (22, 24, 25, 28, 35). However, doses are typically very high (>20g/day) 
which may cause gastrointestinal distress (16, 17, 22, 22, 24, 25). Few studies have 
evaluated whether low dose creatine supplementation improves exercise performance and 
none have evaluated 3g/day on repeated sprint cycling performance. Results of the 
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current study are consistent with and extend previous studies indicating that low doses of 
creatine are effective in increasing exercise performance (11, 28, 49). Hoffman et al (28) 
found that 6g/day for 6 days reduced the rate of decline (slope) in total work over 3 
sprints versus placebo during repeated Wingate sprints. In a study with a similar dosing 
regimen, Rawson et al (49) found that 2.3 g/day for 6 weeks enhanced resistance to 
fatigue in resistance exercise. In the current study, we found that creatine 
supplementation, compared to placebo and creatine and sodium bicarbonate 
supplementation, had a significantly higher slope (reduced rate of decline) in peak power 
over six sprints. Additionally, placebo and creatine and sodium bicarbonate groups 
experienced a steeper slope (greater rate of decline) in mean power and relative mean 
power over six sprints from pre to post supplementation. The creatine group experienced 
no change in slope (rate of decline) over six sprints from pre to post supplementation. 
Taken together, these data suggest that low-dose, creatine supplementation improves 
repeated sprint performance. 
Many studies indicate that creatine supplementation increases short duration, 
high-intensity exercise performance (22, 24, 25, 28, 35). Evidence for positive effects on 
longer duration, aerobic activity is limited. Van Loon et al (58) observed that creatine 
supplementation did not improve 20 minute cycling time trial performance. To our 
knowledge, the present study is the only study to examine the effects of creatine 
supplementation, with and without sodium bicarbonate supplement, on a 5-k cycling time 
trial.  We observed improved performance (decreased time to completion, and increased 
mean speed and mean power) with creatine supplementation, but no impact of placebo or 
creatine plus sodium bicarbonate supplementation in a 5-k time trial.  Study differences 
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in time-trial performance with creatine supplementation may hinge on; 1) Previous 
studies have used time trials that are longer in duration than the current study. Research 
indicates that creatine is effective in increasing performance for short-term activities (7). 
In the study by Van Loon et al (58), the duration (≥20 minutes) may have been too long 
for creatine to have a positive effect on time trial performance.  Whereas in the current 
study, mean 5-km time trial was 9.6 minutes and appears to be short enough in duration 
for creatine supplementation to have a positive impact 2) In the current study, creatine 
supplementation took place over 8 weeks (3g/day). Van Loon et al (58) used lower doses 
of creatine per day (2g/day) and took place over a shorter amount of time (6 weeks); it is 
possible that the creatine supplementation was not high enough or long enough to have a 
positive effect on time trial performance (58).  Nonetheless, our data supports positive 
benefits of creatine supplementation on 5-km time trial performance, but warrants further 
investigation to determine longer duration aerobic performance.   
The exact mechanism of how creatine supplementation improves exercise 
performance remains unclear. However, creatine supplementation has been shown to 
increase total creatine and creatine phosphate levels which may improve performance by 
aiding in the rephosphorylation of ADP to ATP, enhancing cross bridge cycling and 
maintenance of tension, and buffering changes in pH (4, 7, 21, 22, 24, 26, 58). Many 
studies have found that short-term (<10 days) creatine supplementation increases both 
muscle and plasma total (PCr + free creatine) creatine (55). In the current study, although 
we did not take blood samples or a muscle biopsy to shed light on a potential mechanism, 
it is quite possible that both muscle and plasma total creatine levels were increased, 
leading to enhanced performance. Two studies with similar dosages to the current study 
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provide evidence for this assumption. Rawson et al (49) found that 2.3 g/day for 6 weeks 
caused a significant increase (182%) in plasma creatine levels. Hultman et al (30) 
examined the effects of 3g/day for 28 days versus 20g/day for 6 days. They found that 
while the rate of creatine uptake is slower in lower dose regimen, there was no difference 
in muscle total creatine concentration between the two groups, both increased by 20%. 
These data suggest that longer, lower dose regimens are as effective in increasing both 
muscle and plasma total creatine levels as short -term high dosing regimens.  
Anecdotally, creatine supplementation has been linked to muscle cramps and 
gastrointestinal distress (42, 55) but little empirical data supports this notion. In the 
current study we found that the creatine group experienced a decrease in muscle cramps 
and nausea. This is in agreement with most other studies (14, 23, 42, 55, 60). Greenwood 
et al (23) found that creatine supplementation (0.3g/kg of body weight for 5 days then 
0.03g/kg of body weight for an additional 115 days) resulted in significantly less 
cramping than placebo. Additionally, creatine supplementation has been used 
successfully as a treatment to alleviate muscle cramps by 60% in dialysis patients (14). 
Ostojic and Ahmetovic (42) found no significant difference in gastrointestinal distress 
between placebo and creatine supplementation (10g/day for 28 days). Taken together, 
these data suggest that creatine supplementation decreases cramps, reduces nausea and 
does not increase the incidence of gastrointestinal distress.  
In contrast to our secondary hypothesis, adding sodium bicarbonate to creatine did 
not have an additive effect on performance. This is in disagreement with the previous 
study by Barber et al (6) showing that supplementation of creatine plus sodium 
bicarbonate had the slowest rate of decline across six repeated sprints and a 7% increase 
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in performance whereas creatine supplementation alone only increased by 4% (6). 
Differences study results may be related to: 1) In the current study the dose of sodium 
bicarbonate was not high enough to have a positive effect. We and others previous 
showed that 0.3-0.5 g/kg of body weight of sodium bicarbonate are needed to increase 
performance (27, 33, 37), 2) Ergogenic effects of sodium bicarbonate increase pH levels 
and increase buffering capacity (34, 54). However, higher pH may interfere with ATP 
synthesis by decreasing creatine kinase activity (34, 54). Increasing creatine kinase 
activity and muscular phosphocreatine stores, and ultimately increasing ATP synthesis, 
are thought to be main ways creatine supplementation increases performance (7).  Thus, 
by adding sodium bicarbonate to creatine supplementation we may have inadvertently 
inhibited the beneficial effect of creatine on ATP synthesis, 3) As with any intervention 
study, it is possible that subjects in the creatine and sodium bicarbonate group did not 
ingest as many of their pills as they reported. However, we took great care in 
administering our treatments (weekly pill pickup and return of pill cases, and 3-4 weekly 
phone calls/ text messages to remind subjects to take pills).  Based on weekly, self-
reported logs subjects consumed 96% in placebo, 97% in creatine, and 97% in creatine 
and sodium bicarbonate with no significant difference (p=0.58) between groups.  Thus, 
we are confident that the negative finding of adding sodium bicarbonate to creatine 
supplementation is a “true” finding and not related to our administration of treatment.  
Results of the current study have real-world significance, and can be used by 
coaches and athletes seeking to improve high-intensity, repeated sprints or cycling time 
trial performance. Using an 8-week, low-dose creatine supplement, we found an 
improvement in peak power slope (rate of decline) (36%) over six repeated sprints and an 
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improvement in time to completion (3%), mean speed (4%), and mean power output 
(12%) during a 5-k time trial. While changes of 3-4% in the time trial may seem small, 
any improvement over 1% is considered a meaningful improvement in a cycling time 
trial (29). Additionally, we observed decreased muscle cramps and nausea with creatine 
supplementation. The implication of these results is that an 8-week, low- dose creatine 
supplementation can effectively improve exercise performance without increasing 
gastrointestinal side effects.  
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California Polytechnic State University 
 
INFORMED CONSENT TO PARTICIPATE IN A RESEARCH PROJECT ON THE 
EFFECTS OF A DIETARY SUPPLEMENT ON EXERCISE PERFORMANCE 
 
INVESTIGATORS: A research project focused on whether a dietary supplement increases exercise 
performance is being conducted by Todd Hagobian, Ph.D. (thagobia@calpoly.edu), Jennifer 
Olmstead, M.S. (jdolmste@calpoly.edu), and student Amanda Morris (amorris@calpoly.edu) in the 
Kinesiology Department at Cal Poly, San Luis Obispo.  
 
NOTE: You are being asked to participate in a research study. Your participation is voluntary. If you 
are a student, your decision whether or not to participate will not have any effect on your academic 
status. Please feel free to ask questions at any time if there is anything you do not understand.   
Please be aware that you are not required to participate in this research, you may omit any items you 
prefer not to answer, and you may discontinue your participation at any time without penalty or loss of 
benefits.  
    
PURPOSE: Athletes are continuously seeking ways to increase exercise performance.  Dietary 
supplements are the most common method to increase exercise performance.  Creatine and sodium 
bicarbonate are two widely studied supplements that may impact exercise performance, but it is 
unclear whether combining these supplements is more beneficial. Also, other supplements such as 
beta alanine, gingko biloba, and rhodiola rosea may increase exercise performance.  The purpose of 
the study is to determine the impact of creatine, creatine plus sodium bicarbonate, and creatine plus 
sodium bicarbonate plus beta alanine, gingko biloba, and rhodiola rosea on exercise performance.  
You will be randomly assigned to one of four groups; 1) placebo, 2) creatine alone, 3) creatine plus 
sodium bicarbonate, 4) creatine plus sodium bicarbonate plus beta alanine, gingko biloba, and 
rhodiola rosea.  You and the data collector will not know which group you are in.  Each supplement 
period will last 8 weeks. Before and after the eight weeks, you will complete two exercise 
performance tests on separate days.  Your participation will include nine visits (see below) and will 
take approximately six hours total.  On seven of these visits you will be asked to exercise.  All visits 
will occur in the Human Performance Laboratory in the Kinesiology Department.  You are being 
asked to participate because you are a normal, healthy man or woman and are 18 to 40 years old.  
Up to 80 subjects will participate in this study.  
 
OVERVIEW OF STUDY: 
Visit 1: Informed consent, measurement of physical characteristics, and questionnaires (~1 hour) 
Visit 2: Maximal oxygen consumption exercise test (~ 1 hour) 
Visits 3 and 4: Familiarization with exercise performance tests (~ 1 hour total)  
Visits 5 and 6:  Exercise performance tests (~1 hour total) 
Visit 7:  Dietary supplement or Placebo randomization (~1 hour) 
Visits 8-9:  Exercise performance tests (~ 1 hour total) 
 
STUDY PROCEDURES:  
Visit 1 – Informed Consent: You will be provided with a full description of the study and have the 
opportunity to ask any questions. At this time you should inform the investigators of any other studies 
that you are participating in.  If you are interested in participating in the study, you will be familiarized 
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with the procedures and equipment, and your body height and body weight will be measured.  You 
will be asked to complete a questionnaire about your health and physical activity levels.  
 
Visit 2 – Maximal oxygen consumption: Maximal oxygen consumption will be determined by 
exercising on a stationary bicycle.  You will be wearing a heart rate monitor and breathe into a 
mouthpiece and tube. A clip will be placed on your nose so that you can only breathe through your 
mouth.  You will begin pedaling at a very easy workload as a warm-up.  You will continue to pedal at 
the same rate while the workload is increased slightly every 2 minutes.  It will become more and more 
difficult to maintain your pedaling rate as the test progresses.  The test will be stopped when you no 
longer wish to continue (test usually lasts a total of 8-15 minutes).  This test is demanding and you 
may feel fatigued after the test.  The results of this standard test will be used to set the appropriate 
level of physical work during the exercise test.   
 
Visit 3 and 4 - Familiarization with exercise tests and questionnaire: This will occur in the 
morning after you have not eaten for the last 8-12 hours.  You will then complete a high-intensity 
exercise test on a stationary bike.  After a 5 minutes warm-up, the researcher will place the 
appropriate workload on the bike and you will be asked to ride as fast and hard as you can for 10 
seconds.  After a 30 second rest, you will complete another 10-second test.  This will continue until 
you have completed 6 sprints total.  During each rest period, you will ride the bike with no workload 
on it and complete a questionnaire to assess whether your stomach is upset.   
 On a separate day, you will complete a 5-kilometer (3.1 mile) time trial on a stationary bike.  
The goal of this exercise test is for you to ride as hard and fast as you can to complete the 5-
kilometer time trial.  You will have control of the workload and be able to adjust it at any time during 
the test.   
Both exercise tests should feel difficult and you will probably feel fatigued near the end.  During 
the test, if you experience any problems (light-headed, nauseous, excessive redness in the face, or 
irregular heart rate) the exercise test will be immediately stopped.  There will be at least 2 CPR 
certified persons in the room during testing at all times.  In the rare event that you experience a 
serious medical emergency you will immediately stop exercising.  One CPR certified individual will 
call 911, and the other CPR certified individual will attend to your needs.        
 
Visits 5 and 6 - Exercise performance tests and questionnaire:  You will complete the two 
exercise tests described above again and this will be your baseline assessment.   
  
Visit 7 - Dietary supplement randomization:  After all the preliminary tests, you will then be 
randomized to one of four groups; 1) placebo, 2) creatine alone, 3) creatine plus sodium bicarbonate, 
or 4) creatine plus sodium bicarbonate plus beta alanine, gingko biloba, and rhodiola rosea.  You will 
take your supplement for eight weeks.  The placebo will be a calcium pill, and the supplements will be 
3 grams of creatine, 1 gram of sodium bicarbonate, 1 gram of ?- alanine, 60 mg of gingko biloba, 
and 350 mg of rhodiola rosea.  All pills will be similar in color and taste, and neither you nor the 
researcher will know which pill you are getting.   
 
Visits 8 and 9 Exercise performance tests and questionnaire:  After eight weeks of taking the 
placebo or supplement, you will complete the two exercise tests and questionnaire mentioned above.  
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RISKS AND DISCOMFORTS: 
Even though the risks are minimal in this study, all possible attempts will be made to minimize the 
risks involved.  Trained individuals will conduct all laboratory procedures with your well being as their 
first priority.  All procedures will be explained and demonstrated until you are comfortable with the 
proposed study.  NOTE:  Since exercising is important in this study, if you are at all uncomfortable 
with exercising at high-intensity you should not participate. 
     Exercise:  During any type of exercise, especially strenuous exercise, there are slight health risks, 
along with the possibility of fatigue and muscle soreness.  These health risks are small in people with 
no prior history of cardiovascular, respiratory or musculoskeletal disease or injury.  Any ordinary 
fatigue or muscle soreness is temporary and usually lasts 24-96 hours. 
     Supplement:  High doses of creatine or sodium bicarbonate supplementation may cause diarrhea 
or your stomach to be upset.  The dose in this study is very small, and there are no short- or long-
term harmful side effects.  However, if you experience any diarrhea, vomiting, or if your stomach is 
upset, contact Dr. Hagobian, Jennifer Olmstead, M.S., or Amanda Morris immediately and stop taking 
your pills.  
 
BENEFITS: There are no direct benefits to you in participating in this study.  These data are collected 
purely for the purposes of research and do not have a clinical or diagnostic value.  However, these 
data may further our understanding of how dietary supplements impact exercise performance.  Also, 
you will gain knowledge about your fitness level.  After completion of the study, you will be offered to 
see the findings from the study.              
 
CONFIDENTIALITY: We are required by federal regulations to protect your confidentiality. All records 
and assessment data from this study will be treated as confidential.  Your name and the fact that you 
are in the study will be kept confidential. Information stored on our computer will be password 
protected.  A participant ID will identify information on worksheets and questionnaires, and be 
decoded using a list kept in a locked cabinet.  Only research staff and the principal investigator will 
have access to the locked cabinet.  All questionnaires and data collection material completed in this 
study will be shredded within seven years after the study’s completion.  
 
COSTS/PAYMENTS: There are no costs to you for your participation in this study. You will not be 
paid for participation, and your participation is strictly voluntary.   
  
YOUR RIGHT TO WITHDRAW FROM THE STUDY: You may refuse to participate at any time.  You 
may change your mind about being in the study and quit after the study has started.  If you are a 
student your decision whether or not to participate will not have any effect on your academic status.  
You may withdraw from the study at any time and for any reason.  Your decision whether or not to 
participate in this study, or a decision to withdraw will not involve any penalty or loss of benefits to 
which you are entitled. 
 
QUESTIONS: If you have questions regarding this study or would like to be informed of the results 
when the study is completed, please feel free to contact Dr. Todd Hagobian (thagobia@calpoly.edu; 
805-756-7511), Jennifer Olmstead, M.S. (jdolmste@calpoly.edu), or Amanda Morris 
(amorris@calpoly.edu).  If you have concerns regarding the manner in which the study is conducted, 
you may contact Dr. Steve Davis, Chair of the Cal Poly Human Subjects Committee, at (805) 756-
2754, sdavis@calpoly.edu, or Dr. Susan Opava, Dean of Research and Graduate Programs, at (805) 
756-1508, sopava@calpoly.edu. 
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     If you agree to voluntarily participate in this research project as described, please indicate your 
agreement by signing below.  Please keep one copy of this form for your reference, and thank you for 
your participation in this research. 
 
____________________________________   ________________ 
                   Signature of Volunteer                                          Date 
 
 
____________________________________   ________________ 
                   Signature of Researcher                                          Date 
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APPENDIX B: 
Health History Questionnaire 
HEALTH & FITNESS HISTORY 
	  
Subject #: ___________________     Date:  _________________ Age: 
_________ 
 
Height (cm): ___________   Weight (kg): _____________   BMI (kg/m2): _____   
 
1.  Have you ever been diagnosed as having any of the following and if yes, how are you 
currently treating the condition? 
Y   N      High Blood Pressure  
 
Y   N      High Cholesterol or High Triglycerides   
 
Y   N      Diabetes   
 
Y   N      Hypoglycemia (low blood sugar) 
 
Y   N      Asthma  
 
2.  Does anyone in your family (immediate family including your grandparents) have a 
history of cardiovascular disease?  (heart attacks, strokes, etc.)  Please explain:  
 
 
 
3.  Does anyone in your family (immediate family including your grandparents) have a 
history of type II diabetes?  Please explain:  
 
 
 
4.  Have you ever had a glucose tolerance test?     Y    N  
       If yes, what were the results?   
 
 
 
5.  Have you ever had a fasting blood sugar test?    Y   N 
       If yes, what were the results?  
 
 
 
6.  For women:  
 
- Are you pregnant or plan on becoming pregnant within the next year?     Y    N 
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- Are you on hormonal birth control (pill, patch, etc) or estrogen replacement?  
Describe in detail (e.g. the type):   
 
 
- What was the date of your last menstruation?  Is your cycle regular? 
 
 
- Do you know the phase of your current menstrual cycle?    Y   N     If yes, 
please explain: 
7.  Do you have any orthopedic or other health problems that may affect your ability to 
perform exercise?  If yes, please explain: 
 
 
 
8.  Are you currently taking any medications, including over-the-counter drugs such as 
aspirin, Tylenol or Ibuprofen?   Please list: 
 
 
 
9.  Do you smoke or use smokeless tobacco?     Y    N   
 
 
 
10.  Do you drink coffee or other caffeinated beverages?  Y    N      What kind, how much 
and how often?  
 
 
 
11.  Please list all vitamins, minerals and herbs and other nutritional supplements you’re 
taking: 
 
 
 
12.  Do you have any food allergies or intolerances?     Y   N     Please describe:  
 
 
 
13.  How would you describe the type of diet you currently eat?  Have you recently been 
on any special diets?  What kinds of diets have you used to lose weight or lower 
cholesterol?   Please list and describe: 
 
 
 
14.  What changes have you made in your diet in the last 6 months?  Have you gained 
or lost more than 10lbs within the last year? 
 
 
 
15.  Do you exercise regularly?    Y    N             What kinds of exercise?   
 
        How often?   
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        Please describe how much walking you do on a daily basis:   
 
 
 
16.  How does your current exercise and physical activity compare to 6 months ago?   1 
year ago? 
 
 
 
17.  Have you had a physical exam in the past two years?    Y   N      Please describe 
your assessment of your overall health:   
 
 
Participant's Signature:   _______________________________            
Date:  __________________ 
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APPENDIX C: 
GI Distress Questionnaire 
 
Subject:________	   	   Date:________	  	  	  	  Visit/Ex	  test:	  Wingate	  	  TT	  	  	  	  	  Pre	  	  	  Post	  
	  
Section	  1:	  	  Upper	  Abdominal	  Problems	  1)	  Do	  you	  have	  reflux?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  2)	  Do	  you	  have	  heartburn?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  3)	  Do	  you	  have	  bloating	  problems?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  4)	  Do	  you	  have	  cramps?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  5)	  Do	  you	  have	  vomiting	  problems?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  6)	  Do	  you	  have	  nausea	  problems?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  
Section	  2:	  	  Lower	  Abdominal	  Problems	  1)	  Do	  you	  have	  intestinal	  cramps?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  2)	  Do	  you	  have	  flatulence?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  3)	  Do	  you	  have	  an	  urge	  to	  defecate?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	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No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  4)	  Do	  you	  have	  left	  abdominal	  pain?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  5)	  Do	  you	  have	  right	  abdominal	  pain?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  6)	  Do	  you	  have	  loose	  stool?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  7)	  Do	  you	  have	  diarrhea?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  	  
Section	  3:	  	  Systemic	  Problems	  1)	  Do	  you	  have	  dizziness	  problems?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  2)	  Do	  you	  have	  a	  headache?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  	  3)	  Do	  you	  have	  a	  muscle	  cramp?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	  
	  4)	  Do	  you	  have	  an	  urge	  to	  urinate?	  0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
No	  problem	   	   	   	   	   	   	   	   	   Worst	  it	  has	  
at	  all	   	   	   	   	   	   	   	   	   	   ever	  been	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APPENDIX D: 
Physical Activity Log Date:	   	   	   	  Subject	  #:	   	   	  	  	  	  
Day	   Time	   Type:	  Aerobic	  or	  
Lifting	  
Intensity:	  
Low,	  Med,	  or	  
High	  
Duration	  
Saturday	   	   	   	   	  
Sunday	   	   	   	   	  
Monday	   	   	   	   	  
Tuesday	   	   	   	   	  
Wednesday	   	   	   	   	  
Thursday	   	   	   	   	  
Friday	   	   	   	   	  
 
 
